Protalix BioTherapeutics ...

AMEX: PLX · Real-Time Price · USD
1.48
-0.04 (-2.63%)
At close: Aug 15, 2025, 3:59 PM
1.50
1.35%
After-hours: Aug 15, 2025, 05:59 PM EDT

Protalix BioTherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
2.93M 8.31M -14.93M -27.58M
Depreciation & Amortization
1.3M 1.19M 1.09M 1.12M
Stock-Based Compensation
3.25M 3.45M 2.08M 2.38M
Other Working Capital
-4K -13.16M -7.17M 13.23M
Other Non-Cash Items
138K -638K -1.23M 3.09M
Deferred Income Tax
236K -3.09M n/a 813K
Change in Working Capital
811K -10.54M -12.02M 9.9M
Operating Cash Flow
8.67M -1.32M -25M -10.29M
Capital Expenditures
-1.28M -1.15M -628K -1.46M
Cash Acquisitions
n/a n/a n/a 53K
Purchase of Investments
-15M -20.42M -16M -37.84M
Sales Maturities Of Investments
20.42M 5M 11M 57.84M
Other Investing Acitivies
83K -142K 593K 327K
Investing Cash Flow
4.22M -16.71M -5.04M 18.92M
Debt Repayment
-20.42M n/a n/a -34.12M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 712K 2K 46.2M
Financial Cash Flow
-16.79M 24.67M 8.24M 12.08M
Net Cash Flow
-3.87M 6.52M -21.87M 20.72M
Free Cash Flow
7.39M -2.47M -25.63M -11.74M